Medica SurB de CV (MEX:MEDICAB) Beneish M-Score: -3.13 (As of Jun. 26, 2026)


MEX:MEDICAB Medica Sur SAB de CV MEX:MEDICAB
84 GF Score
Price MXN60.77
GF Value MXN47.66
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Medica SurB de CV Beneish M-Score?

Medica SurB de CV MEX:MEDICAB 84 Beneish M-Score is -3.13 as of Jun. 26, 2026. GuruFocus rates MEX:MEDICAB with a GF Score™ of 84/100 and a GF Value™ of MXN47.66 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 633 Healthcare Providers & Services companies, Medica SurB de CV ranks better than 82.31% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.13 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Medica SurB de CV's Beneish M-Score or its related term are showing as below:

MEX:MEDICAB' s Beneish M-Score Range Over the Past 10 Years
Min: -3.13   Med: -2.57   Max: -1.29
Current: -3.13

During the past 13 years, the highest Beneish M-Score of Medica SurB de CV was -1.29. The lowest was -3.13. And the median was -2.57.


Medica SurB de CV Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Medica SurB de CV's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medica SurB de CV Beneish M-Score Chart

Medica SurB de CV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.76 -1.89 -1.94 -2.87 -3.13

Medica SurB de CV Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.87 -2.80 -3.08 -3.24 -3.13

MEX:MEDICAB vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Medica SurB de CV's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medica SurB de CV Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medica SurB de CV's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medica SurB de CV's Beneish M-Score falls into.


MEX:MEDICAB
84GF Score
Medica Sur SAB de CV MEX:MEDICAB
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medica SurB de CV Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medica SurB de CV for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7095+0.528 * 0.9454+0.404 * 0.9755+0.892 * 1.0877+0.115 * 0.9717
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0037+4.679 * -0.089756-0.327 * 1.0053
=-3.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was MXN231 Mil.
Revenue was 1222.686 + 1179.971 + 1181.304 + 1204.931 = MXN4,789 Mil.
Gross Profit was 440.272 + 410.809 + 434.474 + 430.586 = MXN1,716 Mil.
Total Current Assets was MXN1,900 Mil.
Total Assets was MXN4,777 Mil.
Property, Plant and Equipment(Net PPE) was MXN2,375 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN200 Mil.
Selling, General, & Admin. Expense(SGA) was MXN936 Mil.
Total Current Liabilities was MXN1,189 Mil.
Long-Term Debt & Capital Lease Obligation was MXN1,003 Mil.
Net Income was 138.52 + 123.529 + 135.855 + 142.346 = MXN540 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = MXN0 Mil.
Cash Flow from Operations was 225.616 + 310.025 + 220.729 + 212.618 = MXN969 Mil.
Total Receivables was MXN300 Mil.
Revenue was 1131.78 + 1117.437 + 1073.86 + 1079.743 = MXN4,403 Mil.
Gross Profit was 380.959 + 371.954 + 356.039 + 382.656 = MXN1,492 Mil.
Total Current Assets was MXN1,558 Mil.
Total Assets was MXN4,411 Mil.
Property, Plant and Equipment(Net PPE) was MXN2,378 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN194 Mil.
Selling, General, & Admin. Expense(SGA) was MXN857 Mil.
Total Current Liabilities was MXN2,002 Mil.
Long-Term Debt & Capital Lease Obligation was MXN12 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(231.252 / 4788.892) / (299.659 / 4402.82)
=0.048289 / 0.068061
=0.7095

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1491.608 / 4402.82) / (1716.141 / 4788.892)
=0.338785 / 0.358359
=0.9454

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1899.906 + 2374.791) / 4776.726) / (1 - (1558.176 + 2377.747) / 4411.202)
=0.105099 / 0.107744
=0.9755

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4788.892 / 4402.82
=1.0877

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(194.172 / (194.172 + 2377.747)) / (200.052 / (200.052 + 2374.791))
=0.075497 / 0.077695
=0.9717

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(935.689 / 4788.892) / (857.086 / 4402.82)
=0.195387 / 0.194668
=1.0037

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1003.212 + 1188.836) / 4776.726) / ((11.561 + 2001.981) / 4411.202)
=0.458902 / 0.456461
=1.0053

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(540.25 - 0 - 968.988) / 4776.726
=-0.089756

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medica SurB de CV has a M-score of -3.13 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.13 mean?
Medica SurB de CV (MEX:MEDICAB) has a Beneish M-Score of -3.13 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medica SurB de CV and its competitors. According to the industry distribution chart, Medica SurB de CV ranks #112 out of 633 companies in the Healthcare Providers & Services industry, placing it in the top 17.7%.
Is Medica SurB de CV's Beneish M-Score too high?
Medica SurB de CV's current Beneish M-Score is -3.13. Based on the distribution chart, Medica SurB de CV ranks #112 out of 633 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medica SurB de CV has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medica SurB de CV ranks #112 out of 633 companies for Beneish M-Score. This places Medica SurB de CV in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medica SurB de CV and its competitors. Medica SurB de CV's current Beneish M-Score is -3.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Based on GuruFocus' analysis, Medica SurB de CV (MEX:MEDICAB) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN47.66, compared to a current price of MXN60.77 — trading 27.5% above its estimated fair value. The current Beneish M-Score is -3.13. Medica SurB de CV's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Medica SurB de CV (MEX:MEDICAB), the current Beneish M-Score is -3.13 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medica SurB de CV (MEX:MEDICAB) Overvalued in 2026?

Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued. The current stock price of MXN60.77 is trading 27.5% above its estimated GF Value™ of MXN47.66. GuruFocus considers Medica SurB de CV to be Modestly Overvalued.

Key valuation signals for MEX:MEDICAB:

  • Beneish M-Score: -3.13
  • GF Value™: MXN47.66 vs. price of MXN60.77 (27.5% above fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the MEX:MEDICAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medica SurB de CV Business Description

Address Puente de Piedra 150, Col. Toriello Guerra,Tlalpan, Mexico, DF, MEX, 14050
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
84GF Score

Get the complete analysis for MEX:MEDICAB

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN60.77
Price
MXN47.66
GF Value